The effects on bone cells of metal ions released from orthopaedic implants. A review

Clinical Cases in Mineral and Bone Metabolism

Volumn 10, Issue 1, 2013, Pages 34-40

  Sansone, Valerio ^a   Pagani, Davide ^a   Melato, Marco ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Adverse effects; Bone cells; Metal ions; Orthopaedic implants; Osteolysis

Indexed keywords

BIOMATERIAL; METAL ION; POLYMER;

BONE CELL; BONE DEFECT; CERAMICS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MECHANICAL STRESS; METAL IMPLANTATION; NONHUMAN; ORTHOPEDIC IMPLANT; OSTEOLYSIS; REVIEW; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

EID: 84878337447     PISSN: 17248914     EISSN: 19713266     Source Type: Journal    
DOI: 10.11138/ccmbm/2013.10.1.034     Document Type: Review

References (75)

1. Kurtz SM, Ong KL, Schmier J, et al. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am 2007;89 Suppl 3: 144-51.
2. Jacobs JJ, Roebuck KA, Archibeck M, Hallab NJ, Glant TT. Osteolysis: basic science. Clin Orthop Relat Res 2001 Dec;(393): 71-7.
3. Hosman AH, van der Mei HC, Bulstra SK, Busscher HJ, Neut D. Effects of metal-on-metal wear on the host immune system and infection in hip arthroplasty. Acta Orthop 2010;81: 526-34.
4. Jacobs JJ, Campbell PA, Y TK. How has the biologic reaction to wear particles changed with newer bearing surfaces? J Am Acad Orthop Surg 2008;16 Suppl 1:S49-55.
5. Gill HS, Grammatopoulos G, Adshead S, Tsialogiannis E, Tsiridis E. Molecular and immune toxicity of CoCr nanoparticles in MoM hip arthroplasty. Trends Mol Med 2012;18: 145-55.
6. Cobb AG, Schmalzreid TP. The clinical significance of metal ion release from cobalt-chromium metal-on-metal hip joint arthroplasty. Proc Inst Mech Eng H 2006;220: 385-98.
7. Billi F, Campbell P. Nanotoxicology of metal wear particles in total joint arthroplasty: a review of current concepts. J Appl Biomater Biomech 2010;8: 1-6.
8. Bowsher JG, Hussain A, Williams PA, Shelton JC. Metal-on-metal hip simulator study of increased wear particle surface area due to 'severe' patient activity. Proc Inst Mech Eng H 2006;220: 279-87.
9. Urban RM, Jacobs JJ, Tomlinson MJ, Gavrilovic J, Black J, Peoc'h M. Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement. J Bone Joint Surg Am 2000;82: 457-76.
10. Doorn PF, Campbell PA, Worrall J, Benya PD, McKellop HA, Amstutz HC. Metal wear particle characterization from metal on metal total hip replacements: transmission electron microscopy study of periprosthetic tissues and isolated particles. J Biomed Mater Res 1998;42: 103-11.
11. Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006;6: 662-8.
12. Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, DeSimone JM. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci USA 2008;105(33): 11613-8.
13. Papageorgiou I, Yin Z, Ladon D, et al. Genotoxic effects of particles of surgical cobalt chrome alloy on human cells of different age in vitro. Mutat Res 2007;619: 45-58.
14. Polyzois I, Nikolopoulos D, Michos I, Patsouris E, Theocharis S. Local and systemic toxicity of nanoscale debris particles in total hip arthroplasty. J Appl Toxicol 2012;32: 255-69.
15. Wang ML, Tuli R, Manner PA, Sharkey PF, Hall DJ, Tuan RS. Direct and indirect induction of apoptosis in human mesenchymal stem cells in response to titanium particles. J Orthop Res 2003;21: 697-707.
16. Walter LR, Marel E, Harbury R, Wearne J. Distribution of chromium and cobalt ions in various blood fractions after resurfacing hip arthroplasty. J Arthroplasty 2008;23: 814-21.
17. Caicedo MS, Desai R, McAllister K, Reddy A, Jacobs JJ, Hallab NJ. Soluble and particulate Co-Cr-Mo alloy implant metals activate the inflammasome danger signaling pathway in human macrophages: a novel mechanism for implant debris reactivity. J Orthop Res 2009;27: 847-54.
18. Antoniou J, Zukor DJ, Mwale F, Minarik W, Petit A, Huk OL. Metal ion levels in the blood of patients after hip resurfacing: a comparison between twenty- eight and thirty-six-millimeter-head metal-on-metal prostheses. J Bone Joint Surg Am 2008;90 Suppl 3: 142-8.
19. Langton DJ, Sprowson AP, Joyce TJ, et al. Blood metal ion concentrations after hip resurfacing arthroplasty: a comparative study of articular surface replacement and Birmingham Hip Resurfacing arthroplasties. J Bone Joint Surg Br 2009;91: 1287-95.
20. Sauve P, Mountney J, Khan T, De Beer J, Higgins B, Grover M. Metal ion levels after metal-on-metal Ring total hip replacement: a 30-year follow-up study. J Bone Joint Surg Br 2007;89: 586-90.
21. Daniel J, Ziaee H, Pradhan C, McMinn DJ. Six-year results of a prospective study of metal ion levels in young patients with metal-on-metal hip resurfacings. J Bone Joint Surg Br 2009;91: 176-9.
22. Krewski D, Yokel RA, Nieboer E, et al. Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J Toxicol Environ Health B Crit Rev 2007;10 Suppl 1: 1-269.
23. Catelas I, Petit A, Zukor DJ, Antoniou J, Huk OL. TNF-alpha secretion and macrophage mortality induced by cobalt and chromium ions in vitro-qualitative analysis of apoptosis. Biomaterials 2003;24: 383-91.
24. Madden EF, Fowler BA. Mechanisms of nephrotoxicity from metal combinations: a review. Drug Chem Toxicol 2000;23: 1-12.
25. Kurosaki K, Nakamura T, Mukai T, Endo T. Unusual findings in a fatal case of poisoning with chromate compounds. Forensic Sci Int 1995;75: 57-65.
26. Murthy RC, Junaid M, Saxena DK. Ovarian dysfunction in mice following chromium (VI) exposure. Toxicol Lett 1996;89: 147-54.
27. Coleman RF, Herrington J, Scales JT. Concentration of wear products in hair, blood, and urine after total hip replacement. Br Med J 1973;1: 527-9.
28. Savory J, Ghribi O. Can studies of aluminium toxicity in vivo and in vitro provide relevant information on the pathogenesis and aetiology of Alzheimer's disease? J Alzheimer's Dis 2007;11: 429-30; discussion 31-2.
29. Yokel RA. The toxicology of aluminium in the brain: a review. Neurotoxicology 2000;21: 813-28.
30. Jeffery EH, Abreo K, Burgess E, Cannata J, Greger JL. Systemic aluminum toxicity: effects on bone, hematopoietic tissue, and kidney. J Toxicol Environ Health 1996;48: 649-65.
31. Wang JX, Fan YB, Gao Y, Hu QH, Wang TC. TiO2 nanoparticles translocation and potential toxicological effect in rats after intraarticular injection. Biomaterials 2009;30: 4590-600.
32. Lu ZY, Gong H, Amemiya T. Aluminium chloride induces retinal changes in the rat. Toxicol Sci 2002;66: 253-60.
33. Daley B, Doherty AT, Fairman B, Case CP. Wear debris from hip or knee replacements causes chromosomal damage in human cells in tissue culture. J Bone Joint Surg Br 2004;86: 598-606.
34. Hallab NJ, Anderson S, Stafford T, Glant T, Jacobs JJ. Lymphocyte responses in patients with total hip arthroplasty. J Orthop Res 2005;23: 384-91.
35. Caicedo O, Villamor E, Forero Y, et al. Relation between vitamin B12 and folate status, and hemoglobin concentration and parasitemia during acute malaria infections in Colombia. Acta Trop 2010;114: 17-21.
36. Hallab NJ, Caicedo M, Finnegan A, Jacobs JJ. Th1 type lymphocyte reactivity to metals in patients with total hip arthroplasty. J Orthop Surg Res 2008;3:6.
37. Milosev I, Trebse R, Kovac S, Cor A, Pisot V. Survivorship and retrieval analysis of Sikomet metal-on-metal total hip replacements at a mean of seven years. J Bone Joint Surg Am 2006;88: 1173-82.
38. Davies AP, Willert HG, Campbell PA, Learmonth ID, Case CP. An unusual lymphocytic perivascular infiltration in tissues around contemporary metal- on-metal joint replacements. J Bone Joint Surg Am 2005;87: 18-27.
39. Hallab NJ, Mikecz K, Vermes C, Skipor A, Jacobs JJ. Differential lymphocyte reactivity to serum-derived metal-protein complexes produced from cobalt-based and titanium-based implant alloy degradation. J Biomed Mater Res 2001;56: 427-36.
40. Hart AJ, Sabah S, Henckel J, Lewis A, Cobb J, Sampson B, Mitchell A, Skinner JA. The painful metal-on-metal hip resurfacing. J Bone Joint Surg Br 2009;91: 738-44.
41. Kwon YM, Thomas P, Summer B, et al. Lymphocyte proliferation responses in patients with pseudotumors following metal-on-metal hip resurfacing arthroplasty. J Orthop Res 2010;28: 444-50.
42. Pandit H, Vlychou M, Whitwell D, et al. Necrotic granulomatous pseudotumours in bilateral resurfacing hip arthoplasties: evidence for a type IV immune response. Virchows Arch 2008;453: 529-34.
43. Back DL, Young DA, Shimmin AJ. How do serum cobalt and chromium levels change after metal-on-metal hip resurfacing? Clin Orthop Relat Res 2005;438: 177-81.
44. Allen MJ, Myer BJ, Millett PJ, Rushton N. The effects of particulate cobalt, chromium and cobalt-chromium alloy on human osteoblast-like cells in vitro. J Bone Joint Surg Br 1997;79: 475-82.
45. Anissian L, Stark A, Dahlstrand H, Granberg B, Good V, Bucht E. Cobalt ions influence proliferation and function of human osteoblast-like cells. Acta Orthop Scand 2002;73: 369-74.
46. Hallab NJ, Vermes C, Messina C, Roebuck KA, Glant TT, Jacobs JJ. Concentration- and composition-dependent effects of metal ions on human MG- 63 osteoblasts. J Biomed Mater Res 2002;60: 420-33.
47. Khokher MA, Goddard NJ, Winder AF, Hughes SPF. The toxicity of metals used in orthopaedic prostheses: an experimental study using human osteoblast metabolism in vitro. Proc Scand Orthop Res Soc 1993:27.
48. Lanzer WL, Davidson JA, Howard GA. Human bone cell proliferation and the effects of implant wear debris: an in vitro study. In: Sudarshan TS, Braza JF, eds. Surface modification technologies V Cambridge: Cambridge University Press, 1992: 49-60.
49. Millett PJ, Sabokbar A, Allen MJ, Myer B, Rushton N. Osteoblast activity around failed total hip replacements: synovial fluid levels of osteocalcin and alkaline phosphatase. Hip International 1995;5: 8-14.
50. Morais S, Carvalho GS, Faria JL, Gomes HT, Sousa JP. In vitro biomineralization by osteoblast-like cells. II. Characterization of cellular culture supernatants. Biomaterials 1998;19: 23-9.
51. Morais S, Sousa JP, Fernandes MH, Carvalho GS. In vitro biomineralization by osteoblast-like cells. I. Retardation of tissue mineralization by metal salts. Biomaterials 1998;19: 13-21.
52. Fernandes MH. Effect of stainless steel corrosion products on in vitro biomineralization. J Biomater Appl 1999;14: 113-68.
53. McKay GC, Macnair R, MacDonald C, Grant MH. Interactions of orthopaedic metals with an immortalized rat osteoblast cell line. Biomaterials 1996;17: 1339-44.
54. Fleury C, Petit A, Mwale F, et al. Effect of cobalt and chromium ions on human MG-63 osteoblasts in vitro: morphology, cytotoxicity, and oxidative stress. Biomaterials 2006;27: 3351-60.
55. Wang JY, Wicklund BH, Gustilo RB, Tsukayama DT. Prosthetic metals interfere with the functions of human osteoblast cells in vitro. Clin Orthop Relat Res 1997: 216-26.
56. Hallab N, Merritt K, Jacobs JJ. Metal sensitivity in patients with orthopaedic implants. J Bone Joint Surg Am 2001;83-A: 428-36.
57. Hodges NJ, Chipman JK. Down-regulation of the DNA-repair endonuclease 8-oxo-guanine DNA glycosylase 1 (hOGG1) by sodium dichromate in cultured human A549 lung carcinoma cells. Carcinogenesis 2002;23: 55-60.
58. Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y, Athanasou NA. Interleukin- 6 and interleukin-11 support human osteoclast formation by a RANKL- independent mechanism. Bone 2003;32: 1-7.
59. Itonaga I, Sabokbar A, Sun SG, et al. Transforming growth factor-beta induces osteoclast formation in the absence of RANKL. Bone 2004;34: 57-64.
60. Niki Y, Matsumoto H, Suda Y, et al. Metal ions induce bone-resorbing cytokine production through the redox pathway in synoviocytes and bone marrow macrophages. Biomaterials 2003;24: 1447-57.
61. Jost-Albrecht K, Hofstetter W. Gene expression by human monocytes from peripheral blood in response to exposure to metals. J Biomed Mater Res B Appl Biomater 2006;76: 449-55.
62. MacQuarrie RA, Fang Chen Y, Coles C, Anderson GI. Wear-particle-induced osteoclast osteolysis: the role of particulates and mechanical strain. J Biomed Mater Res B Appl Biomater 2004;69: 104-12.
63. Nichols KG, Puleo DA. Effect of metal ions on the formation and function of osteoclastic cells in vitro. J Biomed Mater Res 1997;35: 265-71.
64. Rousselle AV, Heymann D, Demais V, Charrier C, Passuti N, Basle MF. Influence of metal ion solutions on rabbit osteoclast activities in vitro. Histol Histopathol 2002;17: 1025-32.
65. Andrews RE, Shah KM, Wilkinson JM, Gartland A. Effects of cobalt and chromium ions at clinically equivalent concentrations after metal-on-metal hip replacement on human osteoblasts and osteoclasts: implications for skeletal health. Bone 2011;49: 717-23.
66. Patntirapong S, Habibovic P, Hauschka PV. Effects of soluble cobalt and cobalt incorporated into calcium phosphate layers on osteoclast differentiation and activation. Biomaterials 2009;30: 548-55.
67. Harris WH. The problem is osteolysis. Clin Orthop Relat Res 1995;311: 46-53.
68. Koivu H, Mackiewicz Z, Takakubo Y, Trokovic N, Pajarinen J, Konttinen YT. RANKL in the osteolysis of AES total ankle replacement implants. Bone 2012;51: 546-52.
69. Park YS, Moon YW, Lim SJ, Yang JM, Ahn G, Choi YL. Early osteolysis following second-generation metal-on-metal hip replacement. J Bone Joint Surg Am 2005;87: 1515-21.
70. Granchi D, Cenni E, Trisolino G, Giunti A, Baldini N. Sensitivity to implant materials in patients undergoing total hip replacement. J Biomed Mater Res B Appl Biomater 2006;77: 257-64.
71. Frigerio E, Pigatto PD, Guzzi G, Altomare G. Metal sensitivity in patients with orthopaedic implants: a prospective study. Contact Dermatitis 2011;64: 273-9.
72. Dumbleton JH, Manley MT, Edidin AA. A literature review of the association between wear rate and osteolysis in total hip arthroplasty. J Arthroplasty 2002;17: 649-61.
73. Kadoya Y, Kobayashi A, Ohashi H. Wear and osteolysis in total joint replacements. Acta Orthop Scand Suppl 1998;278: 1-16.
74. Engh CA, Hooten JP, Jr., Zettl-Schaffer KF, Ghaffarpour M, McGovern TF, Bobyn JD. Evaluation of bone ingrowth in proximally and extensively porous-coated anatomic medullary locking prostheses retrieved at autopsy. J Bone Joint Surg Am 1995;77: 903-10.
75. Gallo J, Goodman SB, Konttinen YT, Raska M. Particle disease: Biologic mechanisms of peri-prosthetic osteolysis in total hip arthroplasty. Innate Immun 2012 Jun 29. [Epub ahead of print] PMID:22751380.